Novo Nordisk Asks Court To Certify Summary Judgment Orders In Insulin Pen Case
NEW HAVEN, Conn. — Novo Nordisk Inc., facing an insulin XE "insulin" pen product liability action filed by a hospital system, asks a federal court to certify orders that “involve two...To view the full article, register now.
Already a subscriber? Click here to view full article